Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Papers, Reports & Submissions

Publications

Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.

CEP Transcript Request

If you would like a transcript for courses completed prior to 2012, please complete the online enquiry form.


Social

The PAGE white paper: Creating an industry where everyone thrivesoutlines the successes and future challenges for p… https://t.co/LUWVcBzM4o

Today, GSK launched their ‘The Value of Vaccines' report. The paper highlights current challenges to how prevention… https://t.co/ODWF3Zy7q3

RT @ScienceAU: Science could unlock longer, healthier lives for us all thanks to work by Australian Nobel Laureate Professor Elizabeth Blac…

Medicines Australia is pleased to be at the @CFAustralia Not for Profit Forum today - What it takes to be be an A-T… https://t.co/hRCD7ToVY6

Medicines NZ hosts Sir Andrew Dillon, CEO of @NICEComms. Discussing challenges for all health systems to work toget… https://t.co/GAdx8Oo7Je

Medicines Australia is pleased to attend Medicines New Zealand's Parliamentary dinner. Health Minister… https://t.co/epq2ABdhE0

At @jimchalmersmp first @PressClubAust address since the election and reflects on reconnecting with the electorate… https://t.co/ohPnE7Hbvs

Great to be part of #biomelbwomen- a celebration of the achievements of women in the bio and pharma sphere in Victo… https://t.co/wAE8WKLYvK

Great to be at the National Press Club today with @DeloitteAU Chris Richardson, learning about workplace trends and… https://t.co/GpFn1498uW

60k Australians have received treatment for HepC since anti-virals became available on PBS. And 9,000 cases of live… https://t.co/XdIoNNvL8p

Effective management of osteoarthritis could have led to an estimated aggregated increased individual annual income… https://t.co/nqthCN5nWc

1 in 5 Australian’s are aware of new medical innovations. Health is increasingly a mainstream topic and the public… https://t.co/XSZWrMMu0t

The economic impact of early retirement due to ill health is an estimated $45.3 billion of GDP and expected to rise… https://t.co/HjbZqK4HlD

Consumer expectations are high when it comes to health. People expect improvements in healthcare over the next 10 y… https://t.co/vlMB2UyMik

Medicines Australia is attending #BIO in #Philadelphia this week as part of the Australia contingent. Great to be p… https://t.co/VY3Zv0lng2

Between 2017 and 2025 the accumulated superannuation loss due to early retirement from ill health is expected to in… https://t.co/qVlHgyOpo1

Top